Marc Stapley

Marc Stapley, CEO of Veracyte, shares insights from the forefront of cancer diagnostics. He discusses the integration of AI and machine learning in testing and emphasizes the role of liquid biopsies for early detection. Stapley also highlights the challenges of false positives and the importance of monitoring minimal residual disease post-treatment. An innovative nasal swab test for lung cancer is unveiled, showcasing how AI can reduce the need for invasive procedures. His vision for expanding diagnostic services emphasizes strategic partnerships for broader access.